3 Global Generics Major, Farm Chemical Maker and Household Brand Stocks With a Strong Future Roadmap: Aurobindo Pharma, Deepak Fertilisers and Godrej Consumer Products

Global generics major, farm chemical maker and household brand stocks give investors exposure to medicines, industrial chemicals and household goods. Volumes, pricing and margins decide how much of that demand turns into profit.

Readers comparing global generics major, farm chemical maker and household brand stocks should weigh growth, margins, cash flow and valuation together instead of leaning on any single number.

This list covers three global generics major, farm chemical maker and household brand stocks: Aurobindo Pharma for generic formulations and active ingredients sold in the US, Europe and emerging markets, Deepak Fertilisers for industrial chemicals, mining chemicals and fertilisers and Godrej Consumer Products for household insecticides, soaps and hair colour sold in India, Indonesia and Africa. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Global Generics Major, Farm Chemical Maker and Household Brand Stocks?

Global generics major, farm chemical maker and household brand stocks are shares of companies that make health products, chemicals or run restaurants. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.

Global Generics Major, Farm Chemical Maker and Household Brand Stocks at a Glance

The table compares size, valuation, return on equity and debt for the three global generics major, farm chemical maker and household brand stocks as of the 14 Oct 2026 close.

Among healthcare, chemicals and consumer stocks, Godrej Consumer trades at a premium to the industry P/E, while Aurobindo Pharma and Deepak Fertilisers trade at a discount.

Why Do Global Generics Major, Farm Chemical Maker and Household Brand Stocks Have a Strong Roadmap in India?

Global generics major, farm chemical maker and household brand stocks have a strong roadmap in India because generic drug demand, mining and farm chemical use and household spending keep adding volumes for these firms. Three drivers stand out.

• Generic demand: Overseas markets buy affordable formulations.
• Mining and farms: Miners and growers buy chemicals and fertilisers.
• Household spending: Families buy insecticides, soaps and hair colour.

Aurobindo Pharma: Generic Formulations and Ingredients Build the Next Leg

Aurobindo Pharma's roadmap rests on generic formulations and active ingredients sold in the US, Europe and emerging markets, with a wide product basket supporting export revenue.

Revenue grew from Rs 23,775.84 crore in FY22 to Rs 34,145.17 crore in FY26, a 43.6% rise, and FY26 revenue was 5.6% higher than FY25. FY26 net profit rose 0.6% to Rs 3,502.97 crore. Over four years, net profit rose from Rs 2,647.11 crore in FY22 to Rs 3,502.97 crore. In Q1 FY27, revenue grew 18.1% to Rs 9,414.58 crore, and net profit rose 25.2% to Rs 1,032.03 crore. Operating margin was 21.61% in FY26 and 23.10% in Q1 FY27 against 21.95% a year earlier.

Debt to equity is 0.21 and return on equity is 9.25%. FY26 operating cash flow was Rs 5,526.37 crore against capital expenditure of Rs 3,104.67 crore. Aurobindo Pharma paid a dividend of Rs 4 per share for FY26, a yield of 0.25%. At a P/E of 25.46 against an industry P/E of 37.59, the stock trades below its industry multiple.

What to watch: Q1 FY27 operating margin was 23.10% against 21.61% for FY26, so margin stability is the figure to follow as volumes grow.

Deepak Fertilisers: Industrial Chemicals and Fertilisers Build the Next Leg

Deepak Fertilisers' roadmap rests on industrial chemicals, mining chemicals and fertilisers, with a mix of industrial and farm demand supporting revenue.

Revenue grew from Rs 7,707.22 crore in FY22 to Rs 11,609.03 crore in FY26, a 50.6% rise, and FY26 revenue was 12.1% higher than FY25. FY26 net profit was Rs 738.76 crore. In Q1 FY27, revenue grew 21.6% to Rs 3,262.21 crore. Operating margin was 15.53% in FY26 and 26.15% in Q1 FY27 against 20.19% a year earlier.

Debt to equity is 0.83 and return on equity is 10.77%. FY26 operating cash flow was Rs 206.23 crore against capital expenditure of Rs 1,570.42 crore. Deepak Fertilisers paid a dividend of Rs 10 per share for FY26, a yield of 0.72%. At a P/E of 17.80 against an industry P/E of 36.60, the stock trades below its industry multiple.

What to watch: Q1 FY27 operating margin was 26.15% against 15.53% for FY26, so margin stability is the figure to follow as volumes grow.

Godrej Consumer Products: Household and Personal Care Brands Drive the Pipeline

Godrej Consumer's roadmap rests on household insecticides, soaps and hair colour sold in India, Indonesia and Africa, with a multi-country brand portfolio supporting sales.

Revenue grew from Rs 12,366.21 crore in FY22 to Rs 15,444.07 crore in FY26, a 24.9% rise, and FY26 revenue was 7.9% higher than FY25. FY26 net profit was Rs 1,861.47 crore. In Q1 FY27, revenue grew 14.2% to Rs 4,277.35 crore, and net profit rose 11.5% to Rs 504.52 crore. Operating margin was 19.45% in FY26.

Debt to equity is 0.35 and return on equity is 14.71%. FY26 operating cash flow was Rs 2,488.47 crore against capital expenditure of Rs 569.53 crore. Godrej Consumer paid a dividend of Rs 20 per share for FY26, a yield of 2.31%. At a P/E of 46.25 against an industry P/E of 34.85, the stock trades above its industry multiple.

What to watch: The P/E of 46.25 sits above the industry P/E of 34.85, so earnings delivery matters for the valuation.

Best Global Generics Major, Farm Chemical Maker and Household Brand Stocks in India: Aurobindo Pharma vs Deepak Fertilisers vs Godrej Consumer on Key Financials

Among the best global generics major, farm chemical maker and household brand stocks in India, Aurobindo Pharma leads on FY26 operating margin and the lowest debt to equity; Deepak Fertilisers leads on FY26 revenue growth and Q1 FY27 revenue growth; Godrej Consumer leads on return on equity and dividend yield. The table puts the numbers side by side.

Healthcare, chemicals and food earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.

How to Evaluate Global Generics Major, Farm Chemical Maker and Household Brand Stocks to Buy Before You Invest

A short checklist keeps the research consistent when you screen global generics major, farm chemical maker and household brand stocks and shortlist global generics major, farm chemical maker and household brand stocks to buy.

1. Compare each stock's P/E with its industry P/E, which differs by company here.
2. Check revenue growth, operating margin and cash flow together.
3. Check whether revenue growth is turning into profit growth, not only sales.
4. Read operating cash flow against capital expenditure to see how growth is funded.
5. Watch debt to equity and interest cover before sizing a position.
6. Spread exposure across companies and business lines instead of one demand cycle.

Check the Univest Screener for live data on these global generics major, farm chemical maker and household brand stocks

Risks to Consider Before Investing in Global Generics Major, Farm Chemical Maker and Household Brand Stocks

• Consumer demand: Spending patterns can shift sales between quarters.
• Input costs: Changes in raw material prices can affect margins.
• Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.

Download the Univest iOS App or Univest Android App to track Aurobindo Pharma, Deepak Fertilisers and Godrej Consumer live.

Final Take: Which Stock Has the Strongest Roadmap?

These three healthcare, chemicals and consumer stocks cover a generics major, a chemical maker and a household brand. Aurobindo Pharma leads on FY26 operating margin and the lowest debt to equity; Deepak Fertilisers leads on FY26 revenue growth and Q1 FY27 revenue growth; Godrej Consumer leads on return on equity and dividend yield.

Across global generics major, farm chemical maker and household brand stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the global generics major, farm chemical maker and household brand stocks to buy discussed here.

FAQs on Global Generics Major, Farm Chemical Maker and Household Brand Stocks

Which are the best global generics major, farm chemical maker and household brand stocks in India with a strong roadmap?

Ans. Aurobindo Pharma, Deepak Fertilisers and Godrej Consumer Products stand out for their roadmaps in a generics major, a chemical maker and a household brand. FY26 revenue growth was 5.6% at Aurobindo Pharma, 12.1% at Deepak Fertilisers and 7.9% at Godrej Consumer, and return on equity ranges from 9.25% to 14.71%.

Is Aurobindo Pharma a good stock to buy now?

Ans. Aurobindo Pharma has a debt to equity ratio of 0.21, a return on equity of 9.25% and a P/E of 25.46 against an industry P/E of 37.59. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.

What is the P/E ratio of Aurobindo Pharma, Deepak Fertilisers and Godrej Consumer?

Ans. The P/E ratio is 25.46 for Aurobindo Pharma (industry 37.59), 17.80 for Deepak Fertilisers (industry 36.60) and 46.25 for Godrej Consumer (industry 34.85). Only Godrej Consumer trades at or above the industry multiple.

Which of these global generics major, farm chemical maker and household brand stocks has the highest return on equity?

Ans. Godrej Consumer Products has the highest return on equity at 14.71%, followed by Deepak Fertilisers at 10.77% and Aurobindo Pharma at 9.25%.

What are the risks of investing in global generics major, farm chemical maker and household brand stocks?

Ans. The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.

How did Aurobindo Pharma, Deepak Fertilisers and Godrej Consumer perform in Q1 FY27?

Ans. Aurobindo Pharma reported revenue of Rs 9,414.58 crore, up 18.1% year on year, and net profit rose 25.2% to Rs 1,032.03 crore. Deepak Fertilisers reported revenue of Rs 3,262.21 crore, up 21.6% year on year. Godrej Consumer Products reported revenue of Rs 4,277.35 crore, up 14.2% year on year, and net profit rose 11.5% to Rs 504.52 crore.

Do global generics major, farm chemical maker and household brand stocks pay dividends?

Ans. Yes, all three companies pay dividends. The dividend yield is 0.25% for Aurobindo Pharma, 0.72% for Deepak Fertilisers and 2.31% for Godrej Consumer, based on dividends declared for FY26.

How can I invest in global generics major, farm chemical maker and household brand stocks in India?

Ans. You can buy global generics major, farm chemical maker and household brand stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.